Orbital Pharma and Nuclear Thrust: The New Space Age Frontiers

By

The race to commercialize space is accelerating with two groundbreaking projects: one aiming to manufacture pharmaceuticals in orbit, the other to propel spacecraft with nuclear reactors. These ventures promise to reshape industries and redefine interplanetary travel. Below, we explore the details through a series of questions and answers.

What is the commercial plan for making drugs in orbit?

A startup called Varda Space Industries has partnered with pharmaceutical firm United Therapeutics to test whether manufacturing drugs in microgravity can yield superior products. The core idea is to crystallize drug compounds aboard orbital platforms, where the absence of gravity may allow molecules to assemble into more uniform, potent, or longer-lasting forms. If successful, these space-made drugs could be brought back to Earth for commercial use. The venture is driven by falling launch costs and the advent of reusable rockets, making such experiments economically viable for the first time.

Orbital Pharma and Nuclear Thrust: The New Space Age Frontiers
Source: www.technologyreview.com

How does microgravity affect drug crystallization?

In microgravity, buoyancy, sedimentation, and convective flows—common on Earth—are nearly eliminated. This allows crystals to grow more slowly and with fewer defects, often resulting in larger, purer, and more perfectly ordered structures. For pharmaceuticals, this can mean improved solubility, stability, or bioavailability. Varda aims to test whether specific drugs can achieve better therapeutic properties when crystallized in orbit, potentially reducing dosages or side effects. Early results from lab studies suggest that the space environment may unlock new polymorphs of existing drugs, which is why companies like United Therapeutics are investing in this frontier.

Why is space-based manufacturing becoming more plausible now?

Two key factors have shifted the economics: dramatically lower launch costs thanks to reusable rockets (like those from SpaceX), and the maturation of commercial space stations and small orbital platforms. Varda itself has developed a compact autofactory that can fit inside a SpaceX Dragon trunk, enabling affordable, frequent missions. The company’s partnership with United Therapeutics also shows that the pharmaceutical industry is willing to take calculated risks for potential high rewards. NASA’s decades of microgravity research—much of it on the International Space Station—have already demonstrated the benefits of space manufacturing, paving the way for private-sector follow-through.

What is NASA's nuclear-powered spacecraft plan?

Shortly before the Artemis II mission, NASA announced an ambitious goal: by the end of 2028, it aims to launch a nuclear reactor-powered interplanetary spacecraft to Mars. This would be the first such mission, using a nuclear thermal or nuclear electric propulsion system to dramatically shorten travel times and increase payload capacity. The project is still shrouded in mystery, but experts believe it could give the US a strategic edge in the race with China for deep-space exploration. The spacecraft would carry a small nuclear reactor that heats propellant (like hydrogen) to produce thrust, or uses the reactor to generate electricity for ion thrusters.

Orbital Pharma and Nuclear Thrust: The New Space Age Frontiers
Source: www.technologyreview.com

How might a nuclear reactor power an interplanetary spacecraft?

Two main designs are under consideration. In nuclear thermal propulsion (NTP), a reactor core heats liquid hydrogen to extreme temperatures, causing it to expand out a nozzle, creating thrust. This provides high efficiency and could cut Mars travel time from nine months to around three months. In nuclear electric propulsion (NEP), the reactor generates electricity to power ion thrusters that accelerate a propellant like xenon. NEP offers even greater fuel efficiency but lower thrust, requiring longer continuous operation. Both systems would require robust shielding to protect spacecraft electronics and crew from radiation. MIT Technology Review interviewed experts who emphasized that the technology is proven on small scales but has never been used for interplanetary human missions.

What are the implications of this nuclear-powered mission?

A successful nuclear-powered Mars flyby or landing would herald a new era in spaceflight. It would dramatically reduce the risk and cost of sending cargo or astronauts to deep space, making regular missions to Mars, the asteroid belt, and even Jupiter feasible. For NASA, it provides a potential edge over China’s growing space capabilities. However, challenges remain: the reactor must be safely launched without catastrophic failure; fuel must be handled carefully; and international treaties regarding nuclear materials in space add complexity. If successful, it could accelerate the timeline for crewed Mars missions and inspire new commercial applications like orbital fuel depots or asteroid mining.

Tags:

Related Articles

Recommended

Discover More

Mastering Meta is running get-rich-quick ads for its AI toolsDecoding Related-Party Transactions: A Comprehensive Guide to Tesla’s $573 Million Corporate WebOrchestrating Multi-Agent AI Systems: A Step-by-Step Guide to Scalable CollaborationHow Not to Let an AI Agent Run Your Café: Lessons from the Google Gemini Bot ExperimentHow to Create Your First AI Agent with the Microsoft Agent Framework